1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells

1α,25-dihydroxyvitamin D3 Interacts with Curcuminoids to Stimulate Amyloid-β Clearance by Macrophages of Alzheimer's Disease Patients

(2017) Ava Masoumi et al.   JOURNAL OF ALZHEIMERS DISEASE

Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells

(2012) Han-Joo Maeng et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

The Effect of Vitamin D3 and Ketoconazole Combination on VDR-mediated P-gp Expression and Function in Human Colon Adenocarcinoma Cells: Implications in Drug Disposition and Resistance

(2011) Bhavani P. Kota et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

ABC Multidrug Transporters: Target for Modulation of Drug Pharmacokinetics and Drug-Drug Interactions

(2011) Beatrice Marquez et al.   CURRENT DRUG TARGETS

Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells

(2011) Gary N. Y. Chan et al.   JOURNAL OF NEUROCHEMISTRY

1 ,25-Dihydroxyvitamin D3 Up-Regulates P-Glycoprotein via the Vitamin D Receptor and Not Farnesoid X Receptor in Both fxr(-/-) and fxr(+/+) Mice and Increased Renal and Brain Efflux of Digoxin in Mice In Vivo

(2011) E. C. Y. Chow et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Is P-glycoprotein Involved in Amyloid-β Elimination Across the Blood–Brain Barrier in Alzheimer’s Disease?

(2010) S Ohtsuki et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier

(2010) X. Wang et al.   MOLECULAR PHARMACOLOGY

Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-  in a Mouse Model of Alzheimer's Disease

(2010) A. M. S. Hartz et al.   MOLECULAR PHARMACOLOGY

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier

(2010) David S. Miller   TRENDS IN PHARMACOLOGICAL SCIENCES

1α,25-dihydroxyvitamin D3triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liverin vivo

(2009) Edwin C. Y. Chow et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver

(2009) Ansar A. Khan et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Up-Regulation of Transporters and Enzymes by the Vitamin D Receptor Ligands, 1 ,25-Dihydroxyvitamin D3 and Vitamin D Analogs, in the Caco-2 Cell Monolayer

(2009) J. Fan et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter

(2009) J. J. Eloranta et al.   MOLECULAR PHARMACOLOGY

Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier

(2008) Vishal S. Narang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Identification of the functional vitamin D response elements in the human MDR1 gene

(2008) Mayumi Saeki et al.   BIOCHEMICAL PHARMACOLOGY

Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line

(2008) Jason A. Zastre et al.   JOURNAL OF NEUROSCIENCE RESEARCH